These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 11460228

  • 1. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
    Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP.
    Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
    [Abstract] [Full Text] [Related]

  • 2. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ.
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [Abstract] [Full Text] [Related]

  • 3. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 4. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 5. Natural history of nonalcoholic steatohepatitis.
    Liou I, Kowdley KV.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A.
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [Abstract] [Full Text] [Related]

  • 7. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U.
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM, Gupte PA, de Vera ME, Ahmad J.
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [Abstract] [Full Text] [Related]

  • 9. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J.
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL.
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [Abstract] [Full Text] [Related]

  • 11. Subacute liver failure in obese women.
    Caldwell SH, Hespenheide EE.
    Am J Gastroenterol; 2002 Aug; 97(8):2058-62. PubMed ID: 12190177
    [Abstract] [Full Text] [Related]

  • 12. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 13. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Heuman D, Coterrell A, Fisher RA, Contos MJ, Mills AS.
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [Abstract] [Full Text] [Related]

  • 14. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ.
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [Abstract] [Full Text] [Related]

  • 15. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J.
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [Abstract] [Full Text] [Related]

  • 16. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 17. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, Boparai N.
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [Abstract] [Full Text] [Related]

  • 18. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M.
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [Abstract] [Full Text] [Related]

  • 19. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L, Lemoine M.
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [Abstract] [Full Text] [Related]

  • 20. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA, Torgerson S, Hayashi PH.
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.